2013 Archive - Netzwerk Genomische Medizin Lungenkrebs

A Genomics-Based Classification of Human Lung Tumors

von NGM-Team | Okt 15, 2013

Journal: The Clinical Lung Cancer Genome Project (CLCGP) and Network Genomic Medicine (NGM), Science Translational Medicine, October 2013. doi: 10.1126/scitranslmed.3006802
Veröffentlichung: Oktober 2013

Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small.cell lung cancer

von NGM-Team | Jul 15, 2013

Journal: Modern Pathology, July 2013. doi:10.1038/modpathol.2013.141
Veröffentlichung: Juli 2013

Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib

von NGM-Team | Jul 15, 2013

Journal: Lung Cancer, Vol 81, No 1, July 2013. doi:10.1016/j.lungcan.2013.02.018
Veröffentlichung: Juli 2013

Lessons Learned From Lung Cancer Genomics: The Emerging Concept of Individualized Diagnostics and Treatment

von NGM-Team | Mai 15, 2013

Journal: Journal of Clinical Oncology, Vol 15, No 15, May 2013, doi:10.1200/jco.2012.45.9867
Veröffentlichung: Mai 2013

FGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implications

von NGM-Team | Apr 15, 2013

Journal: Translational lung cancer research, Vol 2, No 2, April 2013, doi:10.3978/j.issn.2218-6751.2013.03.03
Veröffentlichung: April 2013

« Ältere Einträge

A Genomics-Based Classification of Human Lung Tumors

Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small.cell lung cancer

Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib

Lessons Learned From Lung Cancer Genomics: The Emerging Concept of Individualized Diagnostics and Treatment

FGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implications

Katgeorien

Archiv